(Q44536830)

3 December 2017

Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease (English)

1 reference

3 December 2017

0 references

1 reference

Heike Kölsch

1

1 reference

3 December 2017

Ursula Ptok

2

1 reference

3 December 2017

Iman Mohamed

3

1 reference

3 December 2017

Sandra Schmitz

4

1 reference

3 December 2017

Marie Luise Rao

5

1 reference

3 December 2017

Wolfgang Maier

6

1 reference

3 December 2017

Reinhard Heun

7

1 reference

3 December 2017

language of work or name

1 reference

1 August 2003

1 reference

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

3 December 2017

1 reference

3 December 2017

121B

1 reference

3 December 2017

1

1 reference

3 December 2017

128-130

1 reference

Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese

3 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Monogenetic determinants of Alzheimer's disease: APP mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Subcellular localization of the low density lipoprotein receptor-related protein (alpha 2-macroglobulin receptor) in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20043

21 January 2018

Identifiers

DOI

10.1002/AJMG.B.20043

1 reference

3 December 2017

1 reference